AmeRuss is launching a phase III multinational study in prepubertal children with growth hormone deficiency (GHD). As part of a global team, AmeRuss will be responsible for initiating 7 sites in Georgia, Armenia, and Belarus. In these 3 sovereignties, AmeRuss will provide full service support for the study conduct. The implementation of this protocol in a region that is a relative newcomer to the community of clinical trials will expand AmeRuss’s experience in the recruitment of subjects for orphan disease therapeutic studies. These countries have already demonstrated admirable efficiency in the pursuit of clinical investigation. AmeRuss is excited about our role in executing this challenging study that promises to facilitate the advent of new treatment in GHD to populations worldwide.